Vancomycin IV Bags Recalled for Sterility Assurance Issues
Central Admixture Pharmacy Services is recalling 3,648 bags of vancomycin IV bags due to lack of assurance of sterility caused by insufficient validation data for decontamination cycles.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall for potential contamination in an intravenous medication does not report illnesses or hospitalizations in the source text. Per the rubric, risk-of-harm products where injury has not been reported score at level 3 (High).
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 3,648 bags of vancomycin 1.5 g/250 mL in 0.9% sodium chloride IV bags due to lack of assurance of sterility. The manufacturer lacked validation data for the decontamination cycles used in preparation.
The recalled product was distributed nationwide. The affected lots and expiration dates are: 36-239524 (7/12/2023), 36-240843 (7/18/2023), 36-241437 (7/20/2023), 36-242698 (7/26/2023), 36-243152 (7/27/2023), 36-245567 (8/2/2023), 36-251063 (8/24/2023), 36-252193 (8/31/2023), and 36-255122, 36-255123, 36-255124 (9/6/2023).
The recalled product
- Product
- vancomycin 1.5 g/250 mL added to 0.9% sodium chloride, 6 mg/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6076-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Injectable / IV
- Hazard
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot: 36-239524
- Exp. 7/12/2023
- 36-240843
- Exp. 7/18/2023
- 36-241437
- Exp. 7/20/2023
- 36-242698
- Exp. 7/26/2023
- 36-243152
- Exp. 7/27/2023
- 36-245567
- Exp. 8/2/2023
- 36-251063
- Exp. 8/24/2023
- 36-252193
- Exp. 8/31/2023
- 36-255122
- 36-255123
- 36-255124
- Exp. 9/6/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27